董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kristiina Vuori | 女 | Director | 49 | 28.81万美元 | 未持股 | 2017-04-20 |
| Ian G. Banwell | 男 | Director | 53 | 未披露 | 未持股 | 2017-04-20 |
| Mark J. Adler | 男 | Director | 60 | 29.46万美元 | 未持股 | 2017-04-20 |
| Neil F. Dimick | 男 | Director | 67 | 31.11万美元 | 未持股 | 2017-04-20 |
| James V. Manning | 男 | Director | 70 | 31.01万美元 | 未持股 | 2017-04-20 |
| Joseph E. Smith | 男 | Director | 78 | 29.06万美元 | 未持股 | 2017-04-20 |
| Martin J. Wygod | 男 | Chairman of the Board | 77 | 508.17万美元 | 未持股 | 2017-04-20 |
| Steven Zatz | 男 | Director and Chief Executive Officer | 60 | 649.49万美元 | 未持股 | 2017-04-20 |
| Stanley S. Trotman, Jr. | 男 | Director | 73 | 29.06万美元 | 未持股 | 2017-04-20 |
| William J. Marino | 男 | Director | 73 | 29.81万美元 | 未持股 | 2017-04-20 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Blake DeSimone | 男 | Executive Vice President and Chief Financial Officer | 40 | 261.54万美元 | 未持股 | 2017-04-20 |
| Rick Treese | 男 | Executive Vice President and Chief Technology Officer | 46 | 未披露 | 未持股 | 2017-04-20 |
| Martin J. Wygod | 男 | Chairman of the Board | 77 | 508.17万美元 | 未持股 | 2017-04-20 |
| Steven Zatz | 男 | Director and Chief Executive Officer | 60 | 649.49万美元 | 未持股 | 2017-04-20 |
| Douglas W. Wamsley | 男 | Executive Vice President, Co-General Counsel and Secretary | 58 | 246.46万美元 | 未持股 | 2017-04-20 |
| Michael B. Glick | 男 | Executive Vice President and Co-General Counsel | 60 | 247.92万美元 | 未持股 | 2017-04-20 |
董事简历
中英对照 | 中文 | 英文- Kristiina Vuori
-
Kristiina Vuori获得学士学位和博士学位，从2014年7月开始担任WebMD董事。Vuori博士从2010年开始一直担任伯纳姆医学研究所（Sanford-Burnham Medical Research Institute）的总裁，从2013年开始担任其临时首席执行官，领导该研究所的学术、科学与综合运营。该研究所是一个非盈利研究机构，致力于研究疾病的最根本的分子层面的原因，并设计未来的创新疗法，其主要的研究项目在癌症、神经退行性疾病、糖尿病与传染病、炎症与儿童疾病领域。Vuori博士还担任该研究所的波林与斯坦利·福斯特主席，并担任该研究所的美国国家癌症研究所（National Cancer Institute，NCI）——指定的癌症中心的教授，这是一项交叉学科的基础与转化研究活动，其调动超过400位的科学家进行研究。从2005年到2013年，Vuori博士还领导了癌症中心。Vuori博士在芬兰的奥卢大学（University of Oulu）获得医学博士学位与博士学位。完成其实习与住院医师实习后，从1992年到1995年，她在伯纳姆医学研究所（Sanford-Burnham）获得博士后学习，并于1996年被任命担任教员。Vuori博士在国家卫生研究所（NIH）、美国国家癌症研究所（NCI）、美国国防部（Department of Defense）、对抗癌症梦之队（Stand Up To Cancer Dream Team）与加州癌症研究计划（California Cancer Research Programs）获得诸多研究经费资助与奖励。她还担任美国国家癌症研究所与其他癌症机构的多个顾问职位，包括美国国家癌症研究所的发展疗法计划、战略科学中心计划与国家癌症咨询委员会的顾问职位。此外，Vuori博士担任美国癌症研究协会（American Association for Cancer Research）、加州再生医学研究院（California Institute for Regenerative Medicine）与加州乳腺癌研究理事会（California Breast Cancer Research Council）。她还担任科学期刊与机构科学顾问委员会的诸多编辑委员会职位。
Kristiina Vuori,has served on Bionano Genomics, Inc. board of directors since May 2019. Since January 1995, Dr. Vuori has served as Professor, and since January 2010 as Pauline and Stanley Foster Distinguished Chair, at the National Cancer Institute-designated Cancer Center of Sanford Burnham Prebys Medical Discovery Institute, or the Institute, a non-profit research organization with programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. In addition, Dr. Vuori served as President and member of the board of directors of the Institute from January 2010 to June 2022, and as the Institute's interim CEO from January 2013 to September 2014, and from September 2017 to June 2020. She served as the Institute's EVP for Scientific Affairs in 2008-2010, as Director of the Cancer Center in 2005-2013, and as Deputy Director of the Cancer Center in 2003-2005. Dr. Vuori has also served as a member of the board of directors of Inhibrx, Inc., a public biotechnology company, since October 2021, of Forian, Inc., a public health data analytics company, since March 2021, and of Sio Gene Therapies, Inc., a public gene therapy company, since October 2020. In addition, Dr. Vuori served on the board of directors of WebMD from July 2014 to September 2017 (when it was acquired by KKR & Co. Inc.) and of the California Institute for Regenerative Medicine, a governmental research institute, from January 2011 to December 2022. Dr. Vuori earned her M.D. and Ph.D. from the University of Oulu, Finland. - Kristiina Vuori获得学士学位和博士学位，从2014年7月开始担任WebMD董事。Vuori博士从2010年开始一直担任伯纳姆医学研究所（Sanford-Burnham Medical Research Institute）的总裁，从2013年开始担任其临时首席执行官，领导该研究所的学术、科学与综合运营。该研究所是一个非盈利研究机构，致力于研究疾病的最根本的分子层面的原因，并设计未来的创新疗法，其主要的研究项目在癌症、神经退行性疾病、糖尿病与传染病、炎症与儿童疾病领域。Vuori博士还担任该研究所的波林与斯坦利·福斯特主席，并担任该研究所的美国国家癌症研究所（National Cancer Institute，NCI）——指定的癌症中心的教授，这是一项交叉学科的基础与转化研究活动，其调动超过400位的科学家进行研究。从2005年到2013年，Vuori博士还领导了癌症中心。Vuori博士在芬兰的奥卢大学（University of Oulu）获得医学博士学位与博士学位。完成其实习与住院医师实习后，从1992年到1995年，她在伯纳姆医学研究所（Sanford-Burnham）获得博士后学习，并于1996年被任命担任教员。Vuori博士在国家卫生研究所（NIH）、美国国家癌症研究所（NCI）、美国国防部（Department of Defense）、对抗癌症梦之队（Stand Up To Cancer Dream Team）与加州癌症研究计划（California Cancer Research Programs）获得诸多研究经费资助与奖励。她还担任美国国家癌症研究所与其他癌症机构的多个顾问职位，包括美国国家癌症研究所的发展疗法计划、战略科学中心计划与国家癌症咨询委员会的顾问职位。此外，Vuori博士担任美国癌症研究协会（American Association for Cancer Research）、加州再生医学研究院（California Institute for Regenerative Medicine）与加州乳腺癌研究理事会（California Breast Cancer Research Council）。她还担任科学期刊与机构科学顾问委员会的诸多编辑委员会职位。
- Kristiina Vuori,has served on Bionano Genomics, Inc. board of directors since May 2019. Since January 1995, Dr. Vuori has served as Professor, and since January 2010 as Pauline and Stanley Foster Distinguished Chair, at the National Cancer Institute-designated Cancer Center of Sanford Burnham Prebys Medical Discovery Institute, or the Institute, a non-profit research organization with programs in cancer, neurodegeneration, diabetes, and infectious, inflammatory, and childhood diseases. In addition, Dr. Vuori served as President and member of the board of directors of the Institute from January 2010 to June 2022, and as the Institute's interim CEO from January 2013 to September 2014, and from September 2017 to June 2020. She served as the Institute's EVP for Scientific Affairs in 2008-2010, as Director of the Cancer Center in 2005-2013, and as Deputy Director of the Cancer Center in 2003-2005. Dr. Vuori has also served as a member of the board of directors of Inhibrx, Inc., a public biotechnology company, since October 2021, of Forian, Inc., a public health data analytics company, since March 2021, and of Sio Gene Therapies, Inc., a public gene therapy company, since October 2020. In addition, Dr. Vuori served on the board of directors of WebMD from July 2014 to September 2017 (when it was acquired by KKR & Co. Inc.) and of the California Institute for Regenerative Medicine, a governmental research institute, from January 2011 to December 2022. Dr. Vuori earned her M.D. and Ph.D. from the University of Oulu, Finland.
- Ian G. Banwell
-
IanG.Banwell自2017年1月起担任WebMD董事会成员。Banwell从2000年到2007年担任Bank of America首席投资官。他于2007年离开Bank of America，开始圆桌投资管理，并担任其首席执行官直到2015年。他目前是Aberdeen Enterprises，LLC的管理合伙人，该公司专注于生产和投资各种知识产权和内容。Banwell先生还从2001年到2012年担任美国财政部（U.S.Treasury）借款咨询委员会的成员，并于2005年和2006年担任其主席。
Ian G. Banwell has been a member of WebMD’s Board of Directors since January 2017. Mr. Banwell was Chief Investment Officer of Bank of America from 2000 to 2007. He left Bank of America in 2007 to start Round Table Investment Management and was its CEO until 2015. He is currently Managing Partner of Aberdeen Enterprises, LLC, a company focused on producing and investing in a variety of intellectual property and content. Mr. Banwell also served as a member of the U.S. Treasury’s Borrowing Advisory Committee from 2001 to 2012 and as its Chairman in 2005 and 2006. - IanG.Banwell自2017年1月起担任WebMD董事会成员。Banwell从2000年到2007年担任Bank of America首席投资官。他于2007年离开Bank of America，开始圆桌投资管理，并担任其首席执行官直到2015年。他目前是Aberdeen Enterprises，LLC的管理合伙人，该公司专注于生产和投资各种知识产权和内容。Banwell先生还从2001年到2012年担任美国财政部（U.S.Treasury）借款咨询委员会的成员，并于2005年和2006年担任其主席。
- Ian G. Banwell has been a member of WebMD’s Board of Directors since January 2017. Mr. Banwell was Chief Investment Officer of Bank of America from 2000 to 2007. He left Bank of America in 2007 to start Round Table Investment Management and was its CEO until 2015. He is currently Managing Partner of Aberdeen Enterprises, LLC, a company focused on producing and investing in a variety of intellectual property and content. Mr. Banwell also served as a member of the U.S. Treasury’s Borrowing Advisory Committee from 2001 to 2012 and as its Chairman in 2005 and 2006.
- Mark J. Adler
-
Mark J. Adler， 2005年9月起，他担任WebMD的董事会成员。2000年9月至2009年10月与WebMD 的总公司HLTH Corporation合并完成，他担任HLTH的董事成员。他是一名肿瘤学家，2011年2月被加州大学（University of California）收购之前10多年，他担任圣地亚哥癌症中心（San Diego Cancer Center）的首席执行官。2014年2月之前，他担任该癌症中心的董事。他目前是圣地亚哥癌症研究学会（San Diego Cancer Research Institute）的董事。2006年4月之前，他在加州圣地亚哥北县Medical Group内科与肿瘤联合部门担任5年多的首席执行官。
Mark J. Adler has been a member of WebMD’s Board of Directors since September 2005. From September 2000 until completion of WebMD’s merger with HLTH Corporation which we refer to as HLTH, the former parent company of WebMD, in October 2009 (which we refer to as the Merger), Dr. Adler was a member of HLTH’s Board of Directors. Since 2014 Dr. Adler has also served as Strategic Advisor to, and as a member of the Scientific Advisory Board of, Biological Dynamics, Inc., a privately held biotechnology company, and is currently the Chairman of that Scientific Advisor Board. He is also currently a director of the San Diego Cancer Research Institute. From February 2011 until February 2014 Dr. Adler served as Director of Strategic Development for UC San Diego Oncology. Dr. Adler, an oncologist, was a co-founder of the San Diego Cancer Center and served for over 10 years as its Chief Executive Officer until February 2011. Until April 2006 Dr. Adler had served, for more than five years, as the Chief Executive Officer of the combined internal medicine and oncology group of Medical Group of North County in San Diego, California. - Mark J. Adler， 2005年9月起，他担任WebMD的董事会成员。2000年9月至2009年10月与WebMD 的总公司HLTH Corporation合并完成，他担任HLTH的董事成员。他是一名肿瘤学家，2011年2月被加州大学（University of California）收购之前10多年，他担任圣地亚哥癌症中心（San Diego Cancer Center）的首席执行官。2014年2月之前，他担任该癌症中心的董事。他目前是圣地亚哥癌症研究学会（San Diego Cancer Research Institute）的董事。2006年4月之前，他在加州圣地亚哥北县Medical Group内科与肿瘤联合部门担任5年多的首席执行官。
- Mark J. Adler has been a member of WebMD’s Board of Directors since September 2005. From September 2000 until completion of WebMD’s merger with HLTH Corporation which we refer to as HLTH, the former parent company of WebMD, in October 2009 (which we refer to as the Merger), Dr. Adler was a member of HLTH’s Board of Directors. Since 2014 Dr. Adler has also served as Strategic Advisor to, and as a member of the Scientific Advisory Board of, Biological Dynamics, Inc., a privately held biotechnology company, and is currently the Chairman of that Scientific Advisor Board. He is also currently a director of the San Diego Cancer Research Institute. From February 2011 until February 2014 Dr. Adler served as Director of Strategic Development for UC San Diego Oncology. Dr. Adler, an oncologist, was a co-founder of the San Diego Cancer Center and served for over 10 years as its Chief Executive Officer until February 2011. Until April 2006 Dr. Adler had served, for more than five years, as the Chief Executive Officer of the combined internal medicine and oncology group of Medical Group of North County in San Diego, California.
- Neil F. Dimick
-
Neil F. Dimick在2003年10月成为公司董事。在2007年5月，Dimick先生成为董事会主席。Dimick先生从2001年8月到2002年5月担任AmerisourceBergen公司执行副总裁，同时担任Bergen Brunswig公司高级执行副总裁以及首席财务官和董事，该公司是AmerisourceBergen公司前身，他还是金融、投资和金融委员会成员，他在以上委员会任职超过5年直到直到2001年与AmeriSource健康公司合并。Dimick先生还在Deloitte & Touche公司（一家审计公司）任职18年，在该公司他担任审计合伙人以及公司房地产部门董事。Dimick目前是以下公司董事会成员，包括联盟图像公司、Mylan实验室公司、资源链接公司以及WebMD公司。
Neil F. Dimick,Prior to joining our Board, Mr. Dimick served as Executive Vice President and Chief Financial Officer of AmerisourceBergen Corporation, a pharmaceutical services provider, from August 2001 to May 2002. He served as Senior Executive Vice President and Chief Financial Officer of Bergen Brunswig Corporation, as well as a director and a member of the Bergen board’s Finance, Investment and Retirement Committees, for more than five years prior to its merger with AmeriSource Health in 2001. Mr. Dimick began his professional career as a corporate auditor with Deloitte & Touche LLP, a professional services firm. He was a partner with the firm for eight years and served for two years as the National Director of the firm’s Real Estate Industry Division. Mr. Dimick currently serves on the board of directors of Viatris, Inc., where he serves as Chairperson of the Audit Committee and member of the Compensation, Executive, and Finance Committees. Mr. Dimick formerly served on the board of Thoratec Corporation, where he was Chairman of the Board and a member of the Audit and Corporate Governance and Nominating Committees; WebMD Health Corp., where he served as a member of the Executive and Audit Committees and as Chairman of the Nominating and Governance Committee; and Alliance HealthCare Services, Inc., where he served as Chairperson of the Audit Committee and member of the Strategic Planning and Finance and Nominating and Corporate Governance Committees. - Neil F. Dimick在2003年10月成为公司董事。在2007年5月，Dimick先生成为董事会主席。Dimick先生从2001年8月到2002年5月担任AmerisourceBergen公司执行副总裁，同时担任Bergen Brunswig公司高级执行副总裁以及首席财务官和董事，该公司是AmerisourceBergen公司前身，他还是金融、投资和金融委员会成员，他在以上委员会任职超过5年直到直到2001年与AmeriSource健康公司合并。Dimick先生还在Deloitte & Touche公司（一家审计公司）任职18年，在该公司他担任审计合伙人以及公司房地产部门董事。Dimick目前是以下公司董事会成员，包括联盟图像公司、Mylan实验室公司、资源链接公司以及WebMD公司。
- Neil F. Dimick,Prior to joining our Board, Mr. Dimick served as Executive Vice President and Chief Financial Officer of AmerisourceBergen Corporation, a pharmaceutical services provider, from August 2001 to May 2002. He served as Senior Executive Vice President and Chief Financial Officer of Bergen Brunswig Corporation, as well as a director and a member of the Bergen board’s Finance, Investment and Retirement Committees, for more than five years prior to its merger with AmeriSource Health in 2001. Mr. Dimick began his professional career as a corporate auditor with Deloitte & Touche LLP, a professional services firm. He was a partner with the firm for eight years and served for two years as the National Director of the firm’s Real Estate Industry Division. Mr. Dimick currently serves on the board of directors of Viatris, Inc., where he serves as Chairperson of the Audit Committee and member of the Compensation, Executive, and Finance Committees. Mr. Dimick formerly served on the board of Thoratec Corporation, where he was Chairman of the Board and a member of the Audit and Corporate Governance and Nominating Committees; WebMD Health Corp., where he served as a member of the Executive and Audit Committees and as Chairman of the Nominating and Governance Committee; and Alliance HealthCare Services, Inc., where he served as Chairperson of the Audit Committee and member of the Strategic Planning and Finance and Nominating and Corporate Governance Committees.
- James V. Manning
-
James V. Manning， 2005年9月起，他担任WebMD的董事会成员。2000年9月至2009年10月合并完成，他担任HLTH的董事会成员。此前，他担任5年多的公司前身董事会成员。
James V. Manning has been a member of WebMD’s Board of Directors since September 2005. From September 2000 until completion of the Merger in October 2009 Mr. Manning was a member of HLTH’s Board of Directors. Prior to that, he was a member of a predecessor company’s board of directors for more than five years. - James V. Manning， 2005年9月起，他担任WebMD的董事会成员。2000年9月至2009年10月合并完成，他担任HLTH的董事会成员。此前，他担任5年多的公司前身董事会成员。
- James V. Manning has been a member of WebMD’s Board of Directors since September 2005. From September 2000 until completion of the Merger in October 2009 Mr. Manning was a member of HLTH’s Board of Directors. Prior to that, he was a member of a predecessor company’s board of directors for more than five years.
- Joseph E. Smith
-
Joseph E. Smith， 2009年10月合并完成起，他担任WebMD的董事会成员。2000年9月至合并，他担任HLTH的董事会成员。1989年3月至1997年9月，他在制药公司Warner-Lambert Company担任多职，最后担任公司执行副总裁和主席与公司管理委员会办公室成员。2012年9月被TPG附属公司收购之前5年，他担任Par Pharmaceutical Companies, Inc.的董事会成员，该公司制造并分销通用和品牌药物。他是私营制药公司NovaMedica的董事会成员。
Joseph E. Smith became a member of WebMD’s Board of Directors in October 2009 upon completion of the Merger. Mr. Smith was a member of HLTH’s Board of Directors from September 2000 until the Merger. Mr. Smith served in various positions with Warner-Lambert Company, a pharmaceutical company, from March 1989 to September 1997 the last of which was Corporate Executive Vice President and a member of the Office of the Chairman and the firm’s Management Committee. Mr. Smith was a member of the Board of Directors of Par Pharmaceutical Companies, Inc., a manufacturer and distributor of generic and branded pharmaceuticals, for more than five years prior to its acquisition by affiliates of TPG in September 2012. Mr. Smith is a member of the Board of Directors of NovaMedica, a privately held pharmaceutical company. - Joseph E. Smith， 2009年10月合并完成起，他担任WebMD的董事会成员。2000年9月至合并，他担任HLTH的董事会成员。1989年3月至1997年9月，他在制药公司Warner-Lambert Company担任多职，最后担任公司执行副总裁和主席与公司管理委员会办公室成员。2012年9月被TPG附属公司收购之前5年，他担任Par Pharmaceutical Companies, Inc.的董事会成员，该公司制造并分销通用和品牌药物。他是私营制药公司NovaMedica的董事会成员。
- Joseph E. Smith became a member of WebMD’s Board of Directors in October 2009 upon completion of the Merger. Mr. Smith was a member of HLTH’s Board of Directors from September 2000 until the Merger. Mr. Smith served in various positions with Warner-Lambert Company, a pharmaceutical company, from March 1989 to September 1997 the last of which was Corporate Executive Vice President and a member of the Office of the Chairman and the firm’s Management Committee. Mr. Smith was a member of the Board of Directors of Par Pharmaceutical Companies, Inc., a manufacturer and distributor of generic and branded pharmaceuticals, for more than five years prior to its acquisition by affiliates of TPG in September 2012. Mr. Smith is a member of the Board of Directors of NovaMedica, a privately held pharmaceutical company.
- Martin J. Wygod
-
Martin J. Wygod，2005年5月起，他担任WebMD的董事会主席。2001年3月至2009年10月合并，他担任HLTH的董事会主席；2000年9月至合并，担任董事会成员。2008年2月至合并，他担任HLTH的代理首席执行官，2000年9月至2003年5月，担任首席执行官。他还从事良种马竞赛、饲养和繁殖。他是River Edge Farm, Inc.的总裁。他成为WebMD的董事会成员的资格包括：曾担任WebMD, HLTH和前身公司的执行官和董事，曾担任保健业其他公司的执行官和董事经验。
Martin J. Wygod has since May 2005 served as Chairman of the Board of WebMD. From March 2001 until the Merger in October 2009 Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing and breeding thoroughbred horses. - Martin J. Wygod，2005年5月起，他担任WebMD的董事会主席。2001年3月至2009年10月合并，他担任HLTH的董事会主席；2000年9月至合并，担任董事会成员。2008年2月至合并，他担任HLTH的代理首席执行官，2000年9月至2003年5月，担任首席执行官。他还从事良种马竞赛、饲养和繁殖。他是River Edge Farm, Inc.的总裁。他成为WebMD的董事会成员的资格包括：曾担任WebMD, HLTH和前身公司的执行官和董事，曾担任保健业其他公司的执行官和董事经验。
- Martin J. Wygod has since May 2005 served as Chairman of the Board of WebMD. From March 2001 until the Merger in October 2009 Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing and breeding thoroughbred horses.
- Steven Zatz
-
Steven Zatz， 2013年8月起，他担任WebMD的总裁，监督WebMD的客户与专业网站与服务。2005年7月至2013年8月，他担任WebMD的专业服务执行副总裁，领导WebMD的专业网站和服务，包括卫生保健专家旗舰网站Medscape.com。 2000年10月至2005年7月，他在HLTH负责类似责任，专注内科门户网站。1999年6月至2000年9月被HLTH收购，他担任CareInsite, Inc.的高级副总裁和医学董事。加入CareInsite之前，1998年10月至1999年5月，他担任RR Donnelly Financial的高级副总裁，负责卫生保健业务。1995年8月至1998年5月，他担任内科门户网站Physicians’Online的总裁。
Steven Zatz has been WebMD’s Chief Executive Officer since September 2016 and a member of its Board of Directors since November 2016. Dr. Zatz has been a member of the senior leadership of WebMD and its predecessor companies for 17 years. Prior to his appointment as Chief Executive Officer, Dr. Zatz was President since August 2013 overseeing WebMD’s consumer and professional websites and services. Prior to that, Dr. Zatz had served as Executive Vice President, Professional Services of WebMD from July 2005 to August 2013 providing leadership for WebMD’s professional websites and services, including its flagship site for healthcare professionals, Medscape.com. From October 2000 to July 2005 Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998 Dr. Zatz was President of Physicians’ Online, an online portal for physicians. - Steven Zatz， 2013年8月起，他担任WebMD的总裁，监督WebMD的客户与专业网站与服务。2005年7月至2013年8月，他担任WebMD的专业服务执行副总裁，领导WebMD的专业网站和服务，包括卫生保健专家旗舰网站Medscape.com。 2000年10月至2005年7月，他在HLTH负责类似责任，专注内科门户网站。1999年6月至2000年9月被HLTH收购，他担任CareInsite, Inc.的高级副总裁和医学董事。加入CareInsite之前，1998年10月至1999年5月，他担任RR Donnelly Financial的高级副总裁，负责卫生保健业务。1995年8月至1998年5月，他担任内科门户网站Physicians’Online的总裁。
- Steven Zatz has been WebMD’s Chief Executive Officer since September 2016 and a member of its Board of Directors since November 2016. Dr. Zatz has been a member of the senior leadership of WebMD and its predecessor companies for 17 years. Prior to his appointment as Chief Executive Officer, Dr. Zatz was President since August 2013 overseeing WebMD’s consumer and professional websites and services. Prior to that, Dr. Zatz had served as Executive Vice President, Professional Services of WebMD from July 2005 to August 2013 providing leadership for WebMD’s professional websites and services, including its flagship site for healthcare professionals, Medscape.com. From October 2000 to July 2005 Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998 Dr. Zatz was President of Physicians’ Online, an online portal for physicians.
- Stanley S. Trotman, Jr.
-
Stanley S. Trotman, Jr.自1996年一直是公司的董事。2001年他从瑞银金融服务公司退休，2000年它收购普惠公司与其合并，普惠是一个投资银行公司，1995年在该公司他曾担任医疗保健组的总经理。他目前是网络医学健康集团和提升医疗保健集团的董事。在1965年Trotman 先生已获得耶鲁大学学士学位，在1967年也获得了哥伦比亚大学商学院的工商管理学硕士学位。
Stanley S. Trotman, Jr., has been a director of the Company since 1996. He was the Managing Director of the Health Care Group at PaineWebber Incorporated since 1995 and retired in 2001 after the company was acquired by UBS Financial Services, Inc. in 2000. He served on the board of directors of WebMD Health Corp. from 2005 to 2017. Mr. Trotman received his undergraduate degree from Yale University in 1965 and obtained an MBA from Columbia Business School in 1967. - Stanley S. Trotman, Jr.自1996年一直是公司的董事。2001年他从瑞银金融服务公司退休，2000年它收购普惠公司与其合并，普惠是一个投资银行公司，1995年在该公司他曾担任医疗保健组的总经理。他目前是网络医学健康集团和提升医疗保健集团的董事。在1965年Trotman 先生已获得耶鲁大学学士学位，在1967年也获得了哥伦比亚大学商学院的工商管理学硕士学位。
- Stanley S. Trotman, Jr., has been a director of the Company since 1996. He was the Managing Director of the Health Care Group at PaineWebber Incorporated since 1995 and retired in 2001 after the company was acquired by UBS Financial Services, Inc. in 2000. He served on the board of directors of WebMD Health Corp. from 2005 to 2017. Mr. Trotman received his undergraduate degree from Yale University in 1965 and obtained an MBA from Columbia Business School in 1967.
- William J. Marino
-
William J. Marino ，2010年11月当选为公司董事。他也是银行的董事。他现任提名委员会与公司治理委员会的主席，亦是资产负债管理委员会/投资委员会的成员。他毕业于圣彼得学院，获得了经济学学士学位。他拥有超过40年的健康和员工福利方面的工作经验，主要是在管理式医疗，营销和管理方面。他曾担任 Horizon Blue Cross Blue Shield of New Jersey（BCBSNJ）的董事长，总裁和首席执行官，这是新泽西最大的健康保险公司，为超过360万人提供服务。他于1992年1月加入Horizon BCBSNJ，担任健康产业服务部高级副总裁，负责新泽西州的管理式医疗所有事务，并负责市场研究，产品开发，供应商关系和医疗保健管理。1994年1月他成为公司总裁兼首席执行官，2010年1月起成为董事长。加盟Horizon BCBSNJ之前，他担任 NY and CT for Prudential的区域副总裁，工作时间长达23年。他目前是新泽西表演艺术中心NJPAC的联合主席，新泽西交响乐团理事会成员，同时他也担任希悦尔公司的董事，组织与薪酬委员会的主席。他是圣文森特学院筹募委员会成员，及莫里斯敦Delbarton School的理事会成员。此外，他是是一家私人控股公司LCA Holdings, LLC的董事。他是1997年爱丽丝岛移民荣誉奖的获得者。 2007年，他获得了美国多样性峰会人道主义年度奖项。他曾担任董事的相它机构包括：美国的健康保险计划；蓝十字蓝盾协会；国家卫生护理管理研究院（前任主席）；选择新泽西；新泽西州商会（前主席）；新泽西网络；纽瓦克联盟；纽瓦克博物馆，自由科学中心主席的顾问委员会；圣彼得学院（前主席）；莫里斯敦的社区剧场；区域业务合作伙伴（前主席）；埃塞克斯郡和西哈德逊（前主席）的联合之路；凯斯勒康复研究所有限公司；纽约卫生业务集团；和纽约州的HMO会议。
William J. Marino is the retired Chairman, President and Chief Executive Officer of Horizon Blue Cross Blue Shield of New Jersey or BCBSNJ, the state’s largest health insurer, providing coverage for over 3.6 million people.Mr. Marino joined Horizon BCBSNJ as Senior Vice President of Health Industry Services in January 1992 responsible for all aspects of Managed Care operations in New Jersey, as well as Market Research, Product Development, Provider Relations and Health Care Management. He became President and CEO in January 1994 and Chairman effective January 2010.Since November 2010 Mr. Marino has served as a director of Sun Bancorp, Inc., where he serves on the Executive Committee, chairs the nominating and corporate governance committee and is a member of the compensation committee. Mr. Marino also serves as a director of WebMD Health Corp., where he is a member of the audit committee. Mr. Marino also serves as a director or trustee for numerous New Jersey-based cultural and community organizations.Mr. Marino has over 40 years of experience in the health and employee benefits field, primarily in managed care, marketing and management. Before joining Horizon BCBSNJ, he was Vice President of Regional Group Operations for New York and Connecticut for Prudential, capping a 23-year career with the company.Mr. Marino has extensive experience in the areas of management and strategic planning and board governance, as evidenced by his career at Horizon BCBSNJ and corporate boards. The breadth of his involvement in many corporate and community organizations has given him knowledge of corporate governance processes and practices and organizational structure optimization. Mr. Marino has been recognized with various awards over the years. He is the recipient of the New Jersey State Chamber 2015 Business Leadership Award. In 2007 he received The American Conference on Diversity’s Humanitarian of the Year Award. Mr. Marino is also a recipient of the 1997 Ellis Island Medal of Honor. He graduated from St. Peter's College in Jersey City with a Bachelor of Science degree in Economics. - William J. Marino ，2010年11月当选为公司董事。他也是银行的董事。他现任提名委员会与公司治理委员会的主席，亦是资产负债管理委员会/投资委员会的成员。他毕业于圣彼得学院，获得了经济学学士学位。他拥有超过40年的健康和员工福利方面的工作经验，主要是在管理式医疗，营销和管理方面。他曾担任 Horizon Blue Cross Blue Shield of New Jersey（BCBSNJ）的董事长，总裁和首席执行官，这是新泽西最大的健康保险公司，为超过360万人提供服务。他于1992年1月加入Horizon BCBSNJ，担任健康产业服务部高级副总裁，负责新泽西州的管理式医疗所有事务，并负责市场研究，产品开发，供应商关系和医疗保健管理。1994年1月他成为公司总裁兼首席执行官，2010年1月起成为董事长。加盟Horizon BCBSNJ之前，他担任 NY and CT for Prudential的区域副总裁，工作时间长达23年。他目前是新泽西表演艺术中心NJPAC的联合主席，新泽西交响乐团理事会成员，同时他也担任希悦尔公司的董事，组织与薪酬委员会的主席。他是圣文森特学院筹募委员会成员，及莫里斯敦Delbarton School的理事会成员。此外，他是是一家私人控股公司LCA Holdings, LLC的董事。他是1997年爱丽丝岛移民荣誉奖的获得者。 2007年，他获得了美国多样性峰会人道主义年度奖项。他曾担任董事的相它机构包括：美国的健康保险计划；蓝十字蓝盾协会；国家卫生护理管理研究院（前任主席）；选择新泽西；新泽西州商会（前主席）；新泽西网络；纽瓦克联盟；纽瓦克博物馆，自由科学中心主席的顾问委员会；圣彼得学院（前主席）；莫里斯敦的社区剧场；区域业务合作伙伴（前主席）；埃塞克斯郡和西哈德逊（前主席）的联合之路；凯斯勒康复研究所有限公司；纽约卫生业务集团；和纽约州的HMO会议。
- William J. Marino is the retired Chairman, President and Chief Executive Officer of Horizon Blue Cross Blue Shield of New Jersey or BCBSNJ, the state’s largest health insurer, providing coverage for over 3.6 million people.Mr. Marino joined Horizon BCBSNJ as Senior Vice President of Health Industry Services in January 1992 responsible for all aspects of Managed Care operations in New Jersey, as well as Market Research, Product Development, Provider Relations and Health Care Management. He became President and CEO in January 1994 and Chairman effective January 2010.Since November 2010 Mr. Marino has served as a director of Sun Bancorp, Inc., where he serves on the Executive Committee, chairs the nominating and corporate governance committee and is a member of the compensation committee. Mr. Marino also serves as a director of WebMD Health Corp., where he is a member of the audit committee. Mr. Marino also serves as a director or trustee for numerous New Jersey-based cultural and community organizations.Mr. Marino has over 40 years of experience in the health and employee benefits field, primarily in managed care, marketing and management. Before joining Horizon BCBSNJ, he was Vice President of Regional Group Operations for New York and Connecticut for Prudential, capping a 23-year career with the company.Mr. Marino has extensive experience in the areas of management and strategic planning and board governance, as evidenced by his career at Horizon BCBSNJ and corporate boards. The breadth of his involvement in many corporate and community organizations has given him knowledge of corporate governance processes and practices and organizational structure optimization. Mr. Marino has been recognized with various awards over the years. He is the recipient of the New Jersey State Chamber 2015 Business Leadership Award. In 2007 he received The American Conference on Diversity’s Humanitarian of the Year Award. Mr. Marino is also a recipient of the 1997 Ellis Island Medal of Honor. He graduated from St. Peter's College in Jersey City with a Bachelor of Science degree in Economics.
高管简历
中英对照 | 中文 | 英文- Blake DeSimone
Blake DeSimone自2016年9月以来一直是WebMD的首席财务官。在此之前，Desimone先生自2015年6月加入WebMD之时起担任WebMD高级副总裁-Finance。担任该职位时，他负责公司的证券交易委员会和财务报告、财务规划和分析以及财务管理。在加入WebMD之前，Desimone先生于2010年至2015年6月担任D+M Holdings（一家全球消费电子公司）的首席财务官。从2007年到2010年，他担任Advogent Group，Inc.（为梦百合行业提供销售与市场营销支持的服务公司）的总裁兼首席财务官。在此之前，他在Cardinal Health和Boron Lepore&Associates，Inc.担任执行职位。Desimone先生是一名注册会计师，在Arthur Andersen&8217；s Assurance Practice开始他的职业生涯。
Blake DeSimone has been WebMD’s Chief Financial Officer since September 2016. Prior to that, Mr. DeSimone served as Senior Vice President - Finance of WebMD from the time that he joined WebMD in June 2015. In that role, he was responsible for the Company’s SEC and financial reporting, financial planning and analysis, and treasury management. Prior to joining WebMD, Mr. DeSimone served as Chief Financial Officer of D+M Holdings, a global consumer electronics company, from 2010 to June 2015. From 2007 to 2010 he was President and Chief Financial Officer of Advogent Group, Inc., a services company providing sales and marketing support to the healthcare industry. Prior to that, he served in executive roles at Cardinal Health and Boron Lepore & Associates, Inc. Mr. DeSimone is a Certified Public Accountant and started his career in Arthur Andersen’s Assurance Practice.- Blake DeSimone自2016年9月以来一直是WebMD的首席财务官。在此之前，Desimone先生自2015年6月加入WebMD之时起担任WebMD高级副总裁-Finance。担任该职位时，他负责公司的证券交易委员会和财务报告、财务规划和分析以及财务管理。在加入WebMD之前，Desimone先生于2010年至2015年6月担任D+M Holdings（一家全球消费电子公司）的首席财务官。从2007年到2010年，他担任Advogent Group，Inc.（为梦百合行业提供销售与市场营销支持的服务公司）的总裁兼首席财务官。在此之前，他在Cardinal Health和Boron Lepore&Associates，Inc.担任执行职位。Desimone先生是一名注册会计师，在Arthur Andersen&8217；s Assurance Practice开始他的职业生涯。
- Blake DeSimone has been WebMD’s Chief Financial Officer since September 2016. Prior to that, Mr. DeSimone served as Senior Vice President - Finance of WebMD from the time that he joined WebMD in June 2015. In that role, he was responsible for the Company’s SEC and financial reporting, financial planning and analysis, and treasury management. Prior to joining WebMD, Mr. DeSimone served as Chief Financial Officer of D+M Holdings, a global consumer electronics company, from 2010 to June 2015. From 2007 to 2010 he was President and Chief Financial Officer of Advogent Group, Inc., a services company providing sales and marketing support to the healthcare industry. Prior to that, he served in executive roles at Cardinal Health and Boron Lepore & Associates, Inc. Mr. DeSimone is a Certified Public Accountant and started his career in Arthur Andersen’s Assurance Practice.
- Rick Treese
Rick Treese自2015年6月以来一直担任WebMD的首席技术官，自2017年1月以来一直担任Vice President的高管。他负责WebMD的技术战略和基础设施，包括支持WebMD&8217；s在线属性的平台的开发。2014年4月至2015年6月，Treese先生担任WebMD工程高级副总裁。Treese先生于2012年加入WebMD，并担任其消费者技术Vice President，直到2014年4月。加入WebMD之前，Treese从2008年到2011年担任Themarkets.com（一家为机构投资者提供金融数据解决方案的供应商）首席技术官。在此之前，Treese从2000年到2008年担任Advanstar Inc.（一家全球媒体公司）首席技术官。
Rick Treese has been WebMD’s Chief Technology Officer since June 2015 and an Executive Vice President since January 2017. He is responsible for WebMD’s technology strategy and infrastructure, including the development of the platforms that support WebMD’s online properties. From April 2014 to June 2015 Mr. Treese was Senior Vice President of Engineering at WebMD. Mr. Treese joined WebMD in 2012 and served as its Vice President, Consumer Technology until April 2014. Before joining WebMD, Mr. Treese was Chief Technology Officer at TheMarkets.com, a provider of financial data solutions for institutional investors, from 2008 to 2011. Prior to that, Mr. Treese was Chief Technology Officer at Advanstar Inc., a global media company, from 2000 to 2008.- Rick Treese自2015年6月以来一直担任WebMD的首席技术官，自2017年1月以来一直担任Vice President的高管。他负责WebMD的技术战略和基础设施，包括支持WebMD&8217；s在线属性的平台的开发。2014年4月至2015年6月，Treese先生担任WebMD工程高级副总裁。Treese先生于2012年加入WebMD，并担任其消费者技术Vice President，直到2014年4月。加入WebMD之前，Treese从2008年到2011年担任Themarkets.com（一家为机构投资者提供金融数据解决方案的供应商）首席技术官。在此之前，Treese从2000年到2008年担任Advanstar Inc.（一家全球媒体公司）首席技术官。
- Rick Treese has been WebMD’s Chief Technology Officer since June 2015 and an Executive Vice President since January 2017. He is responsible for WebMD’s technology strategy and infrastructure, including the development of the platforms that support WebMD’s online properties. From April 2014 to June 2015 Mr. Treese was Senior Vice President of Engineering at WebMD. Mr. Treese joined WebMD in 2012 and served as its Vice President, Consumer Technology until April 2014. Before joining WebMD, Mr. Treese was Chief Technology Officer at TheMarkets.com, a provider of financial data solutions for institutional investors, from 2008 to 2011. Prior to that, Mr. Treese was Chief Technology Officer at Advanstar Inc., a global media company, from 2000 to 2008.
- Martin J. Wygod
Martin J. Wygod，2005年5月起，他担任WebMD的董事会主席。2001年3月至2009年10月合并，他担任HLTH的董事会主席；2000年9月至合并，担任董事会成员。2008年2月至合并，他担任HLTH的代理首席执行官，2000年9月至2003年5月，担任首席执行官。他还从事良种马竞赛、饲养和繁殖。他是River Edge Farm, Inc.的总裁。他成为WebMD的董事会成员的资格包括：曾担任WebMD, HLTH和前身公司的执行官和董事，曾担任保健业其他公司的执行官和董事经验。
Martin J. Wygod has since May 2005 served as Chairman of the Board of WebMD. From March 2001 until the Merger in October 2009 Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing and breeding thoroughbred horses.- Martin J. Wygod，2005年5月起，他担任WebMD的董事会主席。2001年3月至2009年10月合并，他担任HLTH的董事会主席；2000年9月至合并，担任董事会成员。2008年2月至合并，他担任HLTH的代理首席执行官，2000年9月至2003年5月，担任首席执行官。他还从事良种马竞赛、饲养和繁殖。他是River Edge Farm, Inc.的总裁。他成为WebMD的董事会成员的资格包括：曾担任WebMD, HLTH和前身公司的执行官和董事，曾担任保健业其他公司的执行官和董事经验。
- Martin J. Wygod has since May 2005 served as Chairman of the Board of WebMD. From March 2001 until the Merger in October 2009 Mr. Wygod served as HLTH’s Chairman of the Board and served as a member of its Board of Directors from September 2000 until the Merger. Mr. Wygod also served as HLTH’s Acting Chief Executive Officer from February 2008 until the Merger and as its Chief Executive Officer from September 2000 until May 2003. He is also engaged in the business of racing and breeding thoroughbred horses.
- Steven Zatz
Steven Zatz， 2013年8月起，他担任WebMD的总裁，监督WebMD的客户与专业网站与服务。2005年7月至2013年8月，他担任WebMD的专业服务执行副总裁，领导WebMD的专业网站和服务，包括卫生保健专家旗舰网站Medscape.com。 2000年10月至2005年7月，他在HLTH负责类似责任，专注内科门户网站。1999年6月至2000年9月被HLTH收购，他担任CareInsite, Inc.的高级副总裁和医学董事。加入CareInsite之前，1998年10月至1999年5月，他担任RR Donnelly Financial的高级副总裁，负责卫生保健业务。1995年8月至1998年5月，他担任内科门户网站Physicians’Online的总裁。
Steven Zatz has been WebMD’s Chief Executive Officer since September 2016 and a member of its Board of Directors since November 2016. Dr. Zatz has been a member of the senior leadership of WebMD and its predecessor companies for 17 years. Prior to his appointment as Chief Executive Officer, Dr. Zatz was President since August 2013 overseeing WebMD’s consumer and professional websites and services. Prior to that, Dr. Zatz had served as Executive Vice President, Professional Services of WebMD from July 2005 to August 2013 providing leadership for WebMD’s professional websites and services, including its flagship site for healthcare professionals, Medscape.com. From October 2000 to July 2005 Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998 Dr. Zatz was President of Physicians’ Online, an online portal for physicians.- Steven Zatz， 2013年8月起，他担任WebMD的总裁，监督WebMD的客户与专业网站与服务。2005年7月至2013年8月，他担任WebMD的专业服务执行副总裁，领导WebMD的专业网站和服务，包括卫生保健专家旗舰网站Medscape.com。 2000年10月至2005年7月，他在HLTH负责类似责任，专注内科门户网站。1999年6月至2000年9月被HLTH收购，他担任CareInsite, Inc.的高级副总裁和医学董事。加入CareInsite之前，1998年10月至1999年5月，他担任RR Donnelly Financial的高级副总裁，负责卫生保健业务。1995年8月至1998年5月，他担任内科门户网站Physicians’Online的总裁。
- Steven Zatz has been WebMD’s Chief Executive Officer since September 2016 and a member of its Board of Directors since November 2016. Dr. Zatz has been a member of the senior leadership of WebMD and its predecessor companies for 17 years. Prior to his appointment as Chief Executive Officer, Dr. Zatz was President since August 2013 overseeing WebMD’s consumer and professional websites and services. Prior to that, Dr. Zatz had served as Executive Vice President, Professional Services of WebMD from July 2005 to August 2013 providing leadership for WebMD’s professional websites and services, including its flagship site for healthcare professionals, Medscape.com. From October 2000 to July 2005 Dr. Zatz had similar responsibilities at HLTH, where he focused on the physician portals. Dr. Zatz was Senior Vice President, Medical Director of CareInsite, Inc. from June 1999 until its acquisition by HLTH in September 2000. Prior to joining CareInsite, Dr. Zatz was a Senior Vice President of RR Donnelly Financial in charge of its healthcare business from October 1998 to May 1999. From August 1995 to May 1998 Dr. Zatz was President of Physicians’ Online, an online portal for physicians.
- Douglas W. Wamsley
Douglas W. Wamsley， 2005年7月至2012年5月，他担任WebMD的执行副总裁、总顾问个秘书长。2012年5月，他担任执行副总裁、共同总顾问和秘书长。2001年9月至2005年7月，他担任HLTH的法律高级副总裁，专注该公司WebMD的分部门。
Douglas W. Wamsley served as Executive Vice President, General Counsel and Secretary of WebMD from July 2005 until May 2012 when he began to serve as Executive Vice President, Co-General Counsel and Secretary. From September 2001 until July 2005 Mr. Wamsley served as Senior Vice President - Legal of HLTH, focusing on its WebMD segment.- Douglas W. Wamsley， 2005年7月至2012年5月，他担任WebMD的执行副总裁、总顾问个秘书长。2012年5月，他担任执行副总裁、共同总顾问和秘书长。2001年9月至2005年7月，他担任HLTH的法律高级副总裁，专注该公司WebMD的分部门。
- Douglas W. Wamsley served as Executive Vice President, General Counsel and Secretary of WebMD from July 2005 until May 2012 when he began to serve as Executive Vice President, Co-General Counsel and Secretary. From September 2001 until July 2005 Mr. Wamsley served as Senior Vice President - Legal of HLTH, focusing on its WebMD segment.
- Michael B. Glick
Michael B. Glick， 2012年5月起，他担任WebMD的执行副总裁和共同总顾问。2007至2012年5月，他担任WebMD的高级副总裁和助理总顾问。此前，他曾在HLTH及其前身担任5年多的高级副总裁和助理总顾问。
Michael B. Glick became Executive Vice President and Co-General Counsel of WebMD in May 2012. He served as Senior Vice President and Assistant General Counsel of WebMD from 2007 until May 2012 and, before that, had served as Senior Vice President and Assistant General Counsel of HLTH and its predecessors for more than five years.- Michael B. Glick， 2012年5月起，他担任WebMD的执行副总裁和共同总顾问。2007至2012年5月，他担任WebMD的高级副总裁和助理总顾问。此前，他曾在HLTH及其前身担任5年多的高级副总裁和助理总顾问。
- Michael B. Glick became Executive Vice President and Co-General Counsel of WebMD in May 2012. He served as Senior Vice President and Assistant General Counsel of WebMD from 2007 until May 2012 and, before that, had served as Senior Vice President and Assistant General Counsel of HLTH and its predecessors for more than five years.